A detailed history of Rossby Financial, Lcc transactions in Humacyte, Inc. stock. As of the latest transaction made, Rossby Financial, Lcc holds 25,000 shares of HUMA stock, worth $97,750. This represents 0.08% of its overall portfolio holdings.

Number of Shares
25,000
Holding current value
$97,750
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$3.46 - $5.81 $86,500 - $145,250
25,000 New
25,000 $126 Million

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $403M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Rossby Financial, Lcc Portfolio

Follow Rossby Financial, Lcc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossby Financial, Lcc, based on Form 13F filings with the SEC.

News

Stay updated on Rossby Financial, Lcc with notifications on news.